Company

Syndax Pharmaceuticals Inc (SNDX)

Standardized SEC financial data for Syndax Pharmaceuticals Inc — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001395937 · NASDAQ · Pharmaceutical Preparations.

Operating margin

-158.4%

Net margin

-165.6%

Revenue growth (YoY)

627.8%

Return on equity

-441.6%

ROIC

-77.1%

Free cash flow

-$323.2M

Debt / equity

5.42×

Current ratio

4.40×

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.5M	$139.7M	$0	$0	$23.7M	$172.4M
R&D expense	$50.4M	$88.2M	$118.5M	$163.0M	$241.6M	$258.8M
SG&A expense	$22.5M	$25.2M	$33.3M	$66.9M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$115.2M	$222.0M	$74.4M	$295.4M	$154.1M	$134.9M
Inventory	—	—	—	$0	$366K	$32.8M
Total current assets	$298.9M	$448.4M	$489.8M	$580.9M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$71.3M	$29.1M	-$133.7M	-$160.6M	-$274.9M	-$323.0M
Capital expenditures	$0	$129K	$0	$0	$0	$187K
Free cash flow	-$71.3M	$29.0M	-$133.7M	-$160.6M

Get SNDX data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/SNDX/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/SNDX/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View SNDX filings on SEC EDGAR →